Efficacy and Safety of HRS-5965 in Patients With PNH Who Are Still Anemia After Anti-C5 Antibody Treatment
Clinical trial NCT06715943 · COMPLETED
Trial details
- NCT number
- NCT06715943
- Sponsor
- Chengdu Suncadia Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-07
- Primary completion
- 2026-01-06
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.